[Prevention of thromboembolism with antiaggregants (author's transl)]
- PMID: 592989
- DOI: 10.1007/BF01305503
[Prevention of thromboembolism with antiaggregants (author's transl)]
Abstract
Experimental investigations have shown that antiaggregants affect the size rather than the rate of venous thrombosis, while clinical trials with prophylactic acetylsalicylic acid have indicated primarily a reduced incidence of pulmonary embolism. Current experiences with acetylsalicylic acid in combination with dipyridamole or low-dose heparin suggest that the incidence of pathology diagnosed by 125I-fibrinogen and of deep vein thrombosis is equally reduced.
Similar articles
-
Are agents affecting platelet functions clinically useful?Am J Med. 1976 Dec;61(6):897-914. doi: 10.1016/0002-9343(76)90414-9. Am J Med. 1976. PMID: 795299 Review.
-
Preventing venous thromboembolism in elderly patients with hip fractures: studies of low-dose heparin, dipyridamole, aspirin, and flurbiprofen.Br Med J. 1977 Feb 26;1(6060):535-7. doi: 10.1136/bmj.1.6060.535. Br Med J. 1977. PMID: 843794 Free PMC article. Clinical Trial.
-
[Critical evaluation of the usefulness of drugs inhibiting platelet function in the prevention of postoperative deep venous thrombosis and in ischemic cardiopathy].Recenti Prog Med. 1980 Apr;68(4):361-81. Recenti Prog Med. 1980. PMID: 6992244 Review. Italian. No abstract available.
-
[Anticoagulation therapy in myocardial infarction (author's transl)].Schweiz Rundsch Med Prax. 1975 Apr 8;64(14):425-32. Schweiz Rundsch Med Prax. 1975. PMID: 765994 Review. German. No abstract available.
-
[Summary: Drugs affecting platelet behaviour; experimental and clinical data (author's transl)].Ther Umsch. 1974 Feb;31(2):84-8. Ther Umsch. 1974. PMID: 4612856 Review. French. No abstract available.